Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Oncogene
|
September 20, 2016
Translational research in neuroendocrine tumors: pitfalls and opportunities
J Capdevila, O Casanovas, R Salazar, et al.
ESMO Open
|
April 26, 2021
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups
D I Quinn, C F Ng, E Grande, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
Cancer Metastasis Reviews
|
August 7, 2015
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
P Jiménez-Fonseca, A Carmona-Bayonas, E Martín-Pérez, et al.
Oncotargets and Therapy
|
October 17, 2017
HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
P Maroto, E Esteban, E Fernández Parra, et al.
Public Health
|
January 7, 2017
The persistent problem of late HIV diagnosis in people with AIDS: a population-based study in Italy, 1999-2013
M Taborelli, S Virdone, L Camoni, et al.
British Journal of Cancer
|
November 12, 2009
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
J L Perez-Gracia, C Prior, F Guillén-Grima, et al.
Oncology Reports
|
December 18, 2010
Fructose transporter GLUT5 expression in clear renal cell carcinoma
V Medina Villaamil, G Aparicio Gallego, L Valbuena Rubira, et al.
Palliative Medicine
|
May 23, 2013
MORECare research methods guidance development: recommendations for ethical issues in palliative and end-of-life care research
Marjolein Gysels, Catherine J Evans, Penney Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2009
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
D Castellano, X Garcia del Muro, J L Pérez-Gracia, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Oncogene
|
September 20, 2016
Translational research in neuroendocrine tumors: pitfalls and opportunities
J Capdevila, O Casanovas, R Salazar, et al.
ESMO Open
|
April 26, 2021
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups
D I Quinn, C F Ng, E Grande, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
Cancer Metastasis Reviews
|
August 7, 2015
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
P Jiménez-Fonseca, A Carmona-Bayonas, E Martín-Pérez, et al.
Oncotargets and Therapy
|
October 17, 2017
HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
P Maroto, E Esteban, E Fernández Parra, et al.
Public Health
|
January 7, 2017
The persistent problem of late HIV diagnosis in people with AIDS: a population-based study in Italy, 1999-2013
M Taborelli, S Virdone, L Camoni, et al.
British Journal of Cancer
|
November 12, 2009
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
J L Perez-Gracia, C Prior, F Guillén-Grima, et al.
Oncology Reports
|
December 18, 2010
Fructose transporter GLUT5 expression in clear renal cell carcinoma
V Medina Villaamil, G Aparicio Gallego, L Valbuena Rubira, et al.
Palliative Medicine
|
May 23, 2013
MORECare research methods guidance development: recommendations for ethical issues in palliative and end-of-life care research
Marjolein Gysels, Catherine J Evans, Penney Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2009
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
D Castellano, X Garcia del Muro, J L Pérez-Gracia, et al.
Page
of 9